Introducing a mechanism for patenting a new potential use for a drug technology for a period of time after publishing clinical trial data, could be a key solution to thefact too many trial results remain unpublished. Ali Pashazadeh, Treehill Partners CEO, comments in an interview with APM Health, after stressing that too few study results overall ever “see the light of day”.
Read the full content on APM Health Europe: https://www.apmhealtheurope.com/story/14336/90220/a-period-of-patent-protection-could-prompt-sponsors-to-publish-missing-clinical-trial-results-%E2%80%93-interview